Inventor · disambiguated record
Maher Albitar
Also filed as: ALBITAR MAHER · ALBITAR MD MAHER
57 granted patents·40 pending applications·173 citations·filing 2002–2025
98Inventor score
Files withQUEST DIAGNOSTICS INVEST INC29QUEST DIAGNOSTICS INVEST LLC19ALBITAR MAHER16UNIV TEXAS9GENOMIC TESTING COOP LCA5
Top patents by PatentIndex Score
97 records- 0196US9546404B2Methods for detecting gene dysregulation by intragenic differential expressionQUEST DIAGNOSTICS INVEST INC·Filed 2015·Granted Jan 17, 2017·19 cites·14 claims
- 0294US8815516B2Methods for detecting gene dysregulation by intragenic differential expressionQUEST DIAGNOSTICS INVEST INC·Filed 2013·Granted Aug 26, 2014·11 cites·20 claims
- 0393US8426133B2Methods for detecting gene dysregulation by intragenic differential expressionSANDERS HEATHER R·Filed 2010·Granted Apr 23, 2013·11 cites·45 claims
- 0493US8093063B2Assay for detecting genetic abnormalities in genomic nucleic acidsALBITAR MAHER·Filed 2007·Granted Jan 10, 2012·17 cites·48 claims
- 0592US11345964B2BCR-ABL truncation mutationsQUEST DIAGNOSTICS INVEST LLC·Filed 2018·Granted May 31, 2022·3 cites·26 claims
- 0692US10093980B2BCR-ABL truncation mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2016·Granted Oct 9, 2018·4 cites·22 claims
- 0792US7943332B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assaysUNIV TEXAS·Filed 2010·Granted May 17, 2011·12 cites·14 claims
- 0891US10435758B2EML4-ALK translocations in lung cancerQUEST DIAGNOSTICS INVEST INC·Filed 2018·Granted Oct 8, 2019·3 cites·12 claims
- 0991US10100365B2Compositions and methods for detecting mutations in JAK2 nucleic acidQUEST DIAGNOSTICS INVEST INC·Filed 2016·Granted Oct 16, 2018·3 cites·11 claims
- 1091US9187788B2Methods for detecting gene dysregulation by intragenic differential expressionQUEST DIAGNOSTICS INVEST INC·Filed 2014·Granted Nov 17, 2015·5 cites·10 claims
- 1191US2025147026A1Bcr-abl variantsQUEST DIAGNOSTICS INVEST LLC·Filed 2024·Application pending·0 cites
- 1290US11639529B2EML4-ALK translocations in lung cancerQUEST DIAGNOSTICS INVEST LLC·Filed 2019·Granted May 2, 2023·2 cites·10 claims
- 1390US8114618B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assaysALBITAR MAHER·Filed 2011·Granted Feb 14, 2012·9 cites·16 claims
- 1489US10954569B2Compositions and methods for detecting mutations in JAK2 nucleic acidQUEST DIAGNOSTICS INVEST LLC·Filed 2018·Granted Mar 23, 2021·2 cites·11 claims
- 1589US9175350B2EML4-ALK translocations in lung cancerSANDERS HEATHER R·Filed 2010·Granted Nov 3, 2015·5 cites·26 claims
- 1689US8501423B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assaysALBITAR MAHER·Filed 2012·Granted Aug 6, 2013·7 cites·6 claims
- 1789US2025138014A1Mpl mutations in jak2 v617f negative patients with myeloproliferative diseaseQUEST DIAGNOSTICS INVEST LLC·Filed 2024·Application pending·0 cites
- 1888US9957573B2EML4-ALK translocations in lung cancerQUEST DIAGNOSTICS INVEST INC·Filed 2015·Granted May 1, 2018·2 cites·9 claims
- 1988US8512948B2Compositions and methods for detecting mutations in JAK2 nucleic acidALBITAR MAHER·Filed 2010·Granted Aug 20, 2013·4 cites·9 claims
- 2088US8232068B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assaysALBITAR MAHER·Filed 2012·Granted Jul 31, 2012·7 cites·13 claims
- 2188US2025361568A1Compositions and methods for detecting mutations in jak2 nucleic acidQUEST DIAGNOSTICS INVEST LLC·Filed 2025·Application pending·0 cites
- 2288US2024168025A1Hematopoietic cell phenotyping using circulating cell-free markersQUEST DIAGNOSTICS INVEST LLC·Filed 2023·Application pending·0 cites
- 2387US8790882B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assaysUNIV TEXAS·Filed 2013·Granted Jul 29, 2014·5 cites·6 claims
- 2486US12305241B2EML4-ALK translocations in lung cancerQUEST DIAGNOSTICS INVEST LLC·Filed 2023·Granted May 20, 2025·0 cites·8 claims
- 2586US7718387B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assaysUNIV TEXAS·Filed 2002·Granted May 18, 2010·13 cites·18 claims
- 2685US9488656B2BCR-ABL truncation mutationsALBITAR MAHER·Filed 2010·Granted Nov 8, 2016·4 cites·22 claims
- 2784US10227657B2Method for high sensitivity detection of MYD88 mutationsNEOGENOMICS LABORATORIES INC·Filed 2016·Granted Mar 12, 2019·2 cites·9 claims
- 2884US9157916B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assaysUNIV TEXAS·Filed 2014·Granted Oct 13, 2015·3 cites·6 claims
- 2984US2025277273A1Eml4-alk translocations in lung cancerQUEST DIAGNOSTICS INVEST LLC·Filed 2025·Application pending·0 cites
- 3082US12153049B2BCR-ABL variantsQUEST DIAGNOSTICS INVEST LLC·Filed 2022·Granted Nov 26, 2024·0 cites·6 claims
- 3182US2023058588A1Circulating microrna as a marker for hepatocellular carcinomaQUEST DIAGNOSTICS INVEST LLC·Filed 2022·Application pending·0 cites
- 3281US9702877B2BCR-ABL variantsALBITAR MAHER·Filed 2009·Granted Jul 11, 2017·4 cites·18 claims
- 3380US10018638B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assaysUNIV TEXAS·Filed 2017·Granted Jul 10, 2018·1 cites·7 claims
- 3479US8841074B2MPL mutations in JAK2 V617F negative patients with myeloproliferative diseaseMA WANLONG·Filed 2010·Granted Sep 23, 2014·1 cites·17 claims
- 3579US8546552B2TMPRSS2 for the diagnosis of prostate diseaseSANDERS HEATHER R·Filed 2010·Granted Oct 1, 2013·1 cites·2 claims
- 3679US2023058329A1Bcr-abl truncation mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2022·Application pending·0 cites
- 3778US12378609B2Compositions and methods for detecting mutations in JAK2 nucleic acidQUEST DIAGNOSTICS INVEST LLC·Filed 2021·Granted Aug 5, 2025·0 cites·12 claims
- 3878US11021758B2Methods for detecting gene dysregulation by intragenic differential expressionQUEST DIAGNOSTICS INVEST LLC·Filed 2019·Granted Jun 1, 2021·0 cites·21 claims
- 3977US10253370B2High-sensitivity sequencing to detect BTK inhibitor resistanceNEOGENOMICS LABORATORIES INC·Filed 2016·Granted Apr 9, 2019·1 cites·14 claims
- 4076US11275088B2BCR-ABL variantsQUEST DIAGNOSTICS INVEST LLC·Filed 2020·Granted Mar 15, 2022·0 cites·6 claims
- 4176US10501809B2Methods for detecting gene dysregulation by intragenic differential expressionQUEST DIAGNOSTICS INVEST LLC·Filed 2018·Granted Dec 10, 2019·0 cites·13 claims
- 4276US10329605B2Method to increase sensitivity of detection of low-occurrence mutationsNEOGENOMICS LABORATORIES INC·Filed 2016·Granted Jun 25, 2019·1 cites·10 claims
- 4376US9378407B2Automated fish reader using learning machinesNEOGENOMICS LAB·Filed 2013·Granted Jun 28, 2016·6 cites·22 claims
- 4475US11421283B2Circulating microRNA as a marker for hepatocellular carcinomaQUEST DIAGNOSTICS INVEST LLC·Filed 2019·Granted Aug 23, 2022·0 cites·15 claims
- 4575US9733249B2MPL mutations in JAK2 V617F negative patients with myeloproliferative diseaseQUEST DIAGNOSTICS INVEST INC·Filed 2014·Granted Aug 15, 2017·0 cites·11 claims
- 4673US2021011019A1Mpl mutations in jak2 v617f negative patients with myeloproliferative diseaseQUEST DIAGNOSTICS INVEST LLC·Filed 2020·Application pending·0 cites
- 4772US11828760B2Hematopoietic cell phenotyping using circulating cell-free markersQUEST DIAGNOSTICS INVEST LLC·Filed 2018·Granted Nov 28, 2023·0 cites·11 claims
- 4871US10782299B2MPL mutations in JAK2 V617F negative patients with myeloproliferative diseaseQUEST DIAGNOSTICS INVEST INC·Filed 2017·Granted Sep 22, 2020·0 cites·5 claims
- 4970US10093985B2Methods for detecting gene dysregulation by intragenic differential expressionQUEST DIAGNOSTICS INVEST INC·Filed 2016·Granted Oct 9, 2018·0 cites·9 claims
- 5070US9336430B2Computer-assisted karyotypingHEALTH DISCOVERY CORP·Filed 2013·Granted May 10, 2016·2 cites·25 claims
Showing the top 50 of 97 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Maher Albitar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →